Individualized medicine using intestinal responses to CFTR potentiators and correctors
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Individualized medicine using intestinal responses to CFTR potentiators and correctors
Authors
Keywords
-
Journal
PEDIATRIC PULMONOLOGY
Volume 51, Issue S44, Pages S23-S34
Publisher
Wiley
Online
2016-09-24
DOI
10.1002/ppul.23553
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice
- (2016) Dragana Vidović et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sources of Variation in Sweat Chloride Measurements in Cystic Fibrosis
- (2016) Joseph M. Collaco et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids
- (2016) Johanna F. Dekkers et al. EUROPEAN RESPIRATORY JOURNAL
- Human Enteroids as a Model of Upper Small Intestinal Ion Transport Physiology and Pathophysiology
- (2016) Jennifer Foulke-Abel et al. GASTROENTEROLOGY
- Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids
- (2016) D.D. Zomer-van Ommen et al. Journal of Cystic Fibrosis
- Potentiator synergy in rectal organoids carrying S1251N, G551D, or F508del CFTR mutations
- (2016) Johanna F. Dekkers et al. Journal of Cystic Fibrosis
- Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment
- (2016) Donald R. VanDevanter et al. Journal of Cystic Fibrosis
- From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
- (2016) Gudio Veit et al. MOLECULAR BIOLOGY OF THE CELL
- Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis
- (2016) Johanna F. Dekkers et al. Science Translational Medicine
- New and emerging targeted therapies for cystic fibrosis
- (2016) Bradley S Quon et al. BMJ-British Medical Journal
- New and emerging targeted therapies for cystic fibrosis
- (2016) Bradley S Quon et al. BMJ-British Medical Journal
- Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study
- (2016) Jane C Davies et al. Lancet Respiratory Medicine
- Progress in therapies for cystic fibrosis
- (2016) Kris De Boeck et al. Lancet Respiratory Medicine
- Intestinal Current Measurements Detect Activation of Mutant CFTR in Patients with Cystic Fibrosis with the G551D Mutation Treated with Ivacaftor
- (2015) Simon Y. Graeber et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
- (2015) Meritxell Huch et al. CELL
- Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
- (2015) Marc van de Wetering et al. CELL
- Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation
- (2015) Frank A.J.A. Bodewes et al. Journal of Cystic Fibrosis
- A bioassay using intestinal organoids to measure CFTR modulators in human plasma
- (2015) R. Dekkers et al. Journal of Cystic Fibrosis
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) Claire E. Wainwright et al. NEW ENGLAND JOURNAL OF MEDICINE
- New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
- (2015) Scott C. Bell et al. PHARMACOLOGY & THERAPEUTICS
- Ivacaftor therapy in siblings with cystic fibrosis-the potential implications of Itraconazole in dosage and efficacy
- (2015) M.J. Harrison et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Management of pancreatic, gastrointestinal and liver complications in adult cystic fibrosis
- (2015) A. Munck et al. REVUE DES MALADIES RESPIRATOIRES
- Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial
- (2015) Richard B Moss et al. Lancet Respiratory Medicine
- Cystic fibrosis transmembrane conductance regulator biomarkers in ‘real life’: can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?
- (2015) Silke van Koningsbruggen-Rietschel et al. Therapeutic Advances in Respiratory Disease
- Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis
- (2014) Steven M. Rowe et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- CFTR functional measurements in human models for diagnosis, prognosis and personalized therapy
- (2014) Jeffrey M. Beekman et al. Journal of Cystic Fibrosis
- Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
- (2014) Kris De Boeck et al. Journal of Cystic Fibrosis
- Cystic fibrosis genetics: from molecular understanding to clinical application
- (2014) Garry R. Cutting NATURE REVIEWS GENETICS
- Adult Stem Cells in the Small Intestine Are Intrinsically Programmed with Their Location-Specific Function
- (2014) Sabine Middendorp et al. STEM CELLS
- PKP-017 Monitoring of ivacaftor serum levels
- (2014) R Trittler et al. European Journal of Hospital Pharmacy-Science and Practice
- A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
- (2014) Michael P Boyle et al. Lancet Respiratory Medicine
- Rectal forceps biopsy procedure in cystic fibrosis: technical aspects and patients perspective for clinical trials feasibility
- (2013) Maria F Servidoni et al. BMC GASTROENTEROLOGY
- Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients
- (2013) Gerald Schwank et al. Cell Stem Cell
- Change in Sweat Chloride as a Clinical End Point in Cystic Fibrosis Clinical Trials
- (2013) Anthony G. Durmowicz et al. CHEST
- Chloride channel-targeted therapy for secretory diarrheas
- (2013) Jay R Thiagarajah et al. CURRENT OPINION IN PHARMACOLOGY
- Mechanism-based corrector combination restores ΔF508-CFTR folding and function
- (2013) Tsukasa Okiyoneda et al. Nature Chemical Biology
- Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
- (2013) Patrick R Sosnay et al. NATURE GENETICS
- A functional CFTR assay using primary cystic fibrosis intestinal organoids
- (2013) Johanna F Dekkers et al. NATURE MEDICINE
- Optimizing Nasal Potential Difference Analysis for CFTR Modulator Development: Assessment of Ivacaftor in CF Subjects with the G551D-CFTR Mutation
- (2013) Steven M. Rowe et al. PLoS One
- Multicenter Intestinal Current Measurements in Rectal Biopsies from CF and Non-CF Subjects to Monitor CFTR Function
- (2013) John P. Clancy et al. PLoS One
- Growing Self-Organizing Mini-Guts from a Single Intestinal Stem Cell: Mechanism and Applications
- (2013) T. Sato et al. SCIENCE
- Cystic Fibrosis Transmembrane Regulator Correctors and Potentiators
- (2013) S. M. Rowe et al. Cold Spring Harbor Perspectives in Medicine
- CFTR biomarkers: time for promotion to surrogate end-point
- (2012) K. De Boeck et al. EUROPEAN RESPIRATORY JOURNAL
- Evaluation of the intestinal current measurement method as a diagnostic test for cystic fibrosis
- (2012) Malena Cohen-Cymberknoh et al. PEDIATRIC PULMONOLOGY
- Measurements of CFTR-Mediated Cl− Secretion in Human Rectal Biopsies Constitute a Robust Biomarker for Cystic Fibrosis Diagnosis and Prognosis
- (2012) Marisa Sousa et al. PLoS One
- Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
- (2011) Toshiro Sato et al. GASTROENTEROLOGY
- Assessment of CFTR function in homozygous R117H-7T subjects
- (2011) R.A. de Nooijer et al. Journal of Cystic Fibrosis
- New clinical diagnostic procedures for cystic fibrosis in Europe
- (2011) K. De Boeck et al. Journal of Cystic Fibrosis
- Isolation and in vitro expansion of human colonic stem cells
- (2011) Peter Jung et al. NATURE MEDICINE
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- The K+ Channel Opener 1-EBIO Potentiates Residual Function of Mutant CFTR in Rectal Biopsies from Cystic Fibrosis Patients
- (2011) Eva K. Roth et al. PLoS One
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- (2011) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for theF508del-CFTRmutation
- (2011) J P Clancy et al. THORAX
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutation
- (2010) Frank J. Accurso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data
- (2010) N. Derichs et al. THORAX
- Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
- (2009) Toshiro Sato et al. NATURE
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
- (2009) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CFTR Function and Prospects for Therapy
- (2008) John R. Riordan Annual Review of Biochemistry
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now